Preliminary studies reveal conolidine may well inhibit specific ion channels, lowering neuronal excitability and limiting pain indicators. This system is particularly applicable in neuropathic discomfort, where by irregular signaling results in persistent discomfort. In addition, conolidine appears to impact G protein-coupled receptor (GPCR) pathwa